Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 35 of 39

  1. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial

  2. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial

  3. allopurinol

    United Therapeutics Europe Ltd

    Gout

    approved small molecule completed

    1 trial

  4. alogliptin+pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  5. aripiprazole

    Otsuka Beijing Research Institute

    Bipolar Disorder

    approved small molecule completed

    1 trial

  6. armodafinil

    Teva Pharma GmbH

    Sleep Disorders

    approved small molecule completed

    1 trial

  7. artemether lumefantrine

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  8. artemether-lumefantrine (ALN)

    United Therapeutics Europe Ltd

    Uncomplicated Malaria

    approved small molecule completed

    1 trial

  9. aspirin 100mg/d therapy

    The First People's Hospital of Lianyungang

    Coronary Atherosclerosis

    approved small molecule active

    1 trial

  10. aspirin and clopidogrel

    The First People's Hospital of Lianyungang

    Atrial Fibrillation

    approved small molecule active

    1 trial

  11. aspirin and/or clopidogrel

    Takeda

    Early Gastric Cancer

    approved small molecule active

    1 trial

  12. berberine hydrochloride

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  13. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

  14. biologics treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Psoriasis

    approved mab active

    1 trial

  15. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  16. brand name metoprolol ER

    BRIGHT MINDS BIOSCIENCES INC.

    Blood Pressure

    approved small molecule completed

    1 trial

  17. brinzolamide 1%/brimonidine 0.2% fixed combination

    Novartis Pharmaceuticals

    Glaucoma

    approved small molecule completed

    1 trial

  18. budesonide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Respiratory Distress Syndrome

    approved small molecule active

    1 trial

  19. budesonide/formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cough Variant Asthma

    approved small molecule active

    1 trial

  20. buprenorphine

    Indivior Pty Ltd

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  21. buprenorphine

    Indivior Pty Ltd

    Hepatitis C, Chronic

    approved small molecule terminated

    1 trial

  22. buprenorphine/naloxone

    BICYCLE THERAPEUTICS

    Opioid Use Disorder

    approved small molecule terminated

    1 trial

  23. buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    3 trials

  24. bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco-Use Disorder

    approved small molecule completed

    1 trial

  25. butylphthalide(NBP)

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule completed

    1 trial

  26. combination NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  27. combined fixed dose combination

    Gain Therapeutics

    Tuberculosis

    approved small molecule active

    1 trial

  28. combined fixed dose combination

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    1 trial

  29. conbercept

    Hospital Authority, Hong Kong

    Polypoidal Choroidal Vasculopathy

    approved small molecule completed

    1 trial

  30. conventional dose epinephrine

    Hospital Authority, Hong Kong

    Croup

    approved small molecule active

    1 trial

  31. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  32. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  33. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

  34. cyclosporine or tacrolimus

    Wyeth is now a wholly owned subsidiary of Pfizer

    Graft Rejection

    approved small molecule completed

    1 trial

  35. dabrafenib

    Novartis Pharmaceuticals

    Melanoma

    approved small molecule active

    1 trial

  36. dapagliflozin

    The First People's Hospital of Lianyungang

    Diabetic Kidney Disease

    approved small molecule active

    1 trial

  37. dexlansoprazole

    Takeda

    Laryngopharyngeal Reflux

    approved small molecule active

    1 trial

  38. dexmedetomidine

    The First People's Hospital of Lianyungang

    Aged

    approved small molecule completed

    3 trials

  39. dexmedetomidine

    Pfizer

    MRI Sedation

    approved small molecule completed

    1 trial

  40. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  41. dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sleep Quality of Patients Undergoing TURP

    approved small molecule completed

    1 trial

  42. dexmedetomidine hydrochloride for injection

    The First People's Hospital of Lianyungang

    Delirium

    approved small molecule completed

    1 trial

  43. diclofenac sodium topical gel

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  44. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial

  45. docetaxel

    Hoffmann-La Roche

    Breast Cancer

    approved small molecule completed

    2 trials

  46. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

  47. dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  48. dupilumab

    Regeneron UK Limited

    Severe Atopic Dermatitis (AD)

    approved small molecule terminated

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.